Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

University of Windsor

$12,119.00

I2I market assessment for epileptic seizure prediction

EF 2015-16

Résumé
A market study will be conducted to assess the viability of commercializing a novel method called GenericPred for epileptic seizure prediction. GenericPred is a mathematical algorithm for time series prediction and is applicable to a variety of fields including medicine, computer science, environmental science and economics. GenericPred has the advantage of being highly adaptable, consistent and computationally efficient. In one potential application, this novel method is used to predict the likely onset of epileptic seizures. Epilepsy afflicts 1 in 100 Canadians and nearly 1% of the global population. Electroencephalogram (EEG) readings record the electrical activity in the brain using flat discs called electrodes that are attached to a person's scalp. When the GenericPred method is applied to continuous EEG data, it can accurately predict when an epileptic seizure will occur. This novel method was evaluated by applying it to pre-recorded EEG data from 21 epileptic patients; the GenericPred method attained an accuracy level with 100% sensitivity and specificity for the prediction of epileptic seizures up to 17 minutes in advance. This method may have the potential to be incorporated as part of a health monitoring or warning system to provide an advance indication of other types of serious health events, such as heart attack and stroke. The ability to predict the onset of a seizure allows for epileptic patients to prepare accordingly to maximize their safety. Devices designed to warn patients of an approaching seizure allows patients to avoid potentially dangerous activities and works toward achieving an enhanced sense of normalcy in their lives. According to a Global Business Intelligence (GBI) Research report, the epilepsy therapeutics market value in eight major countries (United States, Canada, France, Germany, Italy, Spain, United Kingdom, Japan) is expected to grow from $3.4 billion in 2012 to $4.5 billion by 2019. This technology offers a potential innovative solution to assist those suffering from epilepsy to more effectively manage their seizures and to increase Canada's presence in the epileptic therapeutic market.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
478915-2015
Name nom
Gras, Robin
Department département
Computer Science, School of
Organization id
37
Institution établissement
University of Windsor
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
12119
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
2952
Research subject group en
Applied mathematics
Research subject group fr
Mathématiques appliquées
Research subject en
Linear and non-linear systems
Research subject fr
Systèmes linéaires et non linéaires
Partie
1
Nb partie
1
Application title
I2I market assessment for epileptic seizure prediction
Keyword
NSERC
Application summary
A market study will be conducted to assess the viability of commercializing a novel method called GenericPred for epileptic seizure prediction. GenericPred is a mathematical algorithm for time series prediction and is applicable to a variety of fields including medicine, computer science, environmental science and economics. GenericPred has the advantage of being highly adaptable, consistent and computationally efficient. In one potential application, this novel method is used to predict the likely onset of epileptic seizures. Epilepsy afflicts 1 in 100 Canadians and nearly 1% of the global population. Electroencephalogram (EEG) readings record the electrical activity in the brain using flat discs called electrodes that are attached to a person's scalp. When the GenericPred method is applied to continuous EEG data, it can accurately predict when an epileptic seizure will occur. This novel method was evaluated by applying it to pre-recorded EEG data from 21 epileptic patients; the GenericPred method attained an accuracy level with 100% sensitivity and specificity for the prediction of epileptic seizures up to 17 minutes in advance. This method may have the potential to be incorporated as part of a health monitoring or warning system to provide an advance indication of other types of serious health events, such as heart attack and stroke. The ability to predict the onset of a seizure allows for epileptic patients to prepare accordingly to maximize their safety. Devices designed to warn patients of an approaching seizure allows patients to avoid potentially dangerous activities and works toward achieving an enhanced sense of normalcy in their lives. According to a Global Business Intelligence (GBI) Research report, the epilepsy therapeutics market value in eight major countries (United States, Canada, France, Germany, Italy, Spain, United Kingdom, Japan) is expected to grow from $3.4 billion in 2012 to $4.5 billion by 2019. This technology offers a potential innovative solution to assist those suffering from epilepsy to more effectively manage their seizures and to increase Canada's presence in the epileptic therapeutic market.